The FDA announced on April 2, 2025, that Amerisource Health Services LLC is recalling Haloperidol Decanoate Injection due to a lack of sterility assurance and detected bacterial contamination. The voluntary Class II recall affects 14,189 vials distributed nationwide.
How to tell if you have it
- Brand: Somerset Therapeutics
- Product: Haloperidol Decanoate Injection, 100 mg/mL*, 1 x 1 mL Single-Dose Vial
- NDC: 68001-581-41
- Lot code: A240482A
- Expiration date: 08/31/2026
The hazard
The recall cites a lack of assurance of sterility, with bacterial contamination detected in some media fill units. The FDA classifies this as a Class II recall.
Context
GovInfoNow's records show Amerisource Health Services LLC has 30 other recalls on record since July 27, 2022. Recent actions include a May 1, 2026, recall for Primidone Tablets due to cross-contamination risk and a March 16, 2026, recall for Meclizine 12.5mg Tablets over failed specifications. Other recent recalls of similar products include a July 1, 2026, Victory Medical Center Pharmacy Glutathione Vials Recall for bacterial contamination risk and an Oct. 15, 2025, ProRx Semaglutide Injection Recall for contamination risk.